info@seagull-health.com

SeagullHealth

语言:

Homepage

Drugs

Opicapone(Ongentys)

Names

奥匹卡朋,阿片哌酮

Indicatons

Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.

Price:

Manufacturer:

BIAL

Dosage form:

CAPSULE

Validity period:

24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Ongentys(Opicapone) Instructions:Uses,Dosage, Side Effects

ONGENTYS is an orally administered medication belonging to the class of peripheral, selective, and reversible catechol-O-methyltransferase (COMT) inhibitors. Its active pharmaceutical ingredient is opicapone. The product is formulated as hard gelatin capsules, available in two dosage strengths, and functions by modulating the metabolism of levodopa, thereby enhancing its therapeutic effects in the management of Parkinson's disease.

Generic name

Opicapone(Ongentys)

English name

Opicapone

Alternative Names

奥匹卡朋,阿片哌酮

Drug prices

Indications

ONGENTYS® is indicated as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing "off" episodes.

Therapeutic Target

Peripheral, selective, and reversible Catechol-O-methyltransferase (COMT) enzyme.

Active Ingredients

Opicapone

Dosage Form

CAPSULE

Specifications

50mg * 90 capsules/box

Dosage and Administration

50 mg orally once daily at bedtime.

Related Columns

Recommended articles

Adverse Reactions of Opicapone (Ongentys)

Opicapone (Ongentys) is an adjunctive therapeutic drug for Parkinson’s disease (PD). As a combination therapy with levodopa/carbidopa, it is indicated to reduce the occurrence of wearing-off phenomena...

What are the Precautions for Opicapone (Ongentys) Administration?

Opicapone (Ongentys) is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor indicated as an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease for the c...

What Are the Purchase Channels for Opicapone (Ongentys)?

Opicapone (Ongentys) is an adjunctive medication for the treatment of Parkinson’s disease. It enhances the efficacy of levodopa by inhibiting the COMT enzyme and is indicated for patients experiencing...

What are the indications for Opicapone (Ongentys)?

Opicapone (Ongentys) is an oral capsule preparation, which was first approved for marketing in the United States in 2020. As a selective and reversible peripheral catechol-O-methyltransferase (COMT) i...

Dosage and Administration, Recommended Dosage of Opicapone (Ongentys)

Opicapone (Ongentys) is a novel, highly selective and reversible peripheral catechol-O-methyltransferase (COMT) inhibitor, which was approved for marketing in the United States in 2020.Dosage and Admi...

Side Effects of Opicapone (Ongentys)

Opicapone (Ongentys) is a selective, reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It is used as an adjunctive therapy to levodopa/carbidopa to improve "off" period sy...

Departments